ANVS - What's Going On With Annovis Shares Today? | Benzinga
Annovis Bio, Inc. (NYSE:ANVS) stock is showing gains during premarket trading on Wednesday, following a significant increase of more than 76% in the previous session.
According to Benzinga Pro, ANVS stock has lost over 34% in the past year.
Rodman & Renshaw analyst Elemer Piros reiterates Annovis Bio with a Buy and maintains a $67 price target.
The company announced new data from its Phase III Parkinson’s study.
The study showed improvements on the Unified ...